Cytokinetics
CYTK
CYTK
190 hedge funds and large institutions have $1.45B invested in Cytokinetics in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
1% less funds holding
Funds holding: 192 → 190 (-2)
17% less capital invested
Capital invested by funds: $1.74B → $1.45B (-$291M)
Holders
190
Holding in Top 10
5
Calls
$10M
Puts
$5.6M
Top Buyers
| 1 | +$92M | |
| 2 | +$13.9M | |
| 3 | +$13.9M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$9.89M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$7.44M |
Top Sellers
| 1 | -$30.7M | |
| 2 | -$26.2M | |
| 3 | -$20.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16.6M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$15.6M |